Platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in glaucoma: a meta-analysis

Biomark Med. 2024 Jan;18(1):39-49. doi: 10.2217/bmm-2023-0651. Epub 2024 Feb 9.

Abstract

Aim: To explore the association between two systemic inflammation markers, platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR), and glaucoma. Materials & methods: The authors searched PubMed, Embase and the Cochrane Library for eligible studies comparing PLR and LMR levels in glaucoma patients and healthy controls. Results: Analysis revealed that glaucoma patients exhibited significantly elevated PLR levels and reduced LMR compared with nonglaucoma controls. These findings were consistent across various glaucoma types, with the exception of secondary glaucoma, where the association with PLR was less significant. Conclusion: The authors found PLR and LMR to be potential valuable biomarkers for glaucoma identification and progression monitoring. These findings highlight the role of systemic inflammation in glaucoma pathogenesis.

Keywords: glaucoma; lymphocyte-to-monocyte ratio; platelet-to-lymphocyte ratio; serum markers; systemic inflammation.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Blood Platelets / pathology
  • Humans
  • Inflammation / pathology
  • Lymphocytes* / pathology
  • Monocytes* / pathology
  • Neutrophils / pathology
  • Retrospective Studies